Manufacturer record
Stride Organics Private Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Stride Organics Private Ltd (Telangana) were declared Not of Standard Quality between February 2021 and May 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
4 records linked to Stride Organics Private Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Pantoprazole Gastro-Resistant Tablets IP 40 mg, | 431Mfg 2024-11 · Exp 2026-04 | The drug failed to indicate the common name of the color contained in the drug on the label of the product, as required by Rule 127(2) of the Drugs Rules, 1945. It was mentioned on the label as Approved Colours UsedLabelling | State Lab, Drugs Control Laboratory, TelanganaState lab | May 2025 |
| Norfloxacin Tablets I.P.400mg, | 4Mfg 2025-02 · Exp 2026-07 | The sample does not comply with respect to Dissolution Test as per IPDissolution | State Lab, Drugs Control Laboratory, TelanganaState lab | May 2025 |
| Cefixime Dispersible Tablets IP 100 mg | oo84Mfg 2024-10 · Exp 2026-03 | MISBRANDED DRUG 1. The sample is deemed to be misbranded as it is labeled only with the words approved colours used but fails to include the common name of the color on the label, as required by Rule 127(2) of the Drugs Rules, 1945. 2. Additionally, the label does not state that the tablets should be dispersed in water immediately before use, as required by the IP 2022 monograph for Cefixime Dispersible tablets. Hence, the drug is deemed Misbranded under section 17 of the Drug and Cosmetics Act, 1940 as it is not labeled in the prescribed manner.Water content | State Lab Drugs Control Laboratory, TelanganaState lab | Feb 2025 |
| Amoxycillin & Potassium Clavulanate Tablets I.P. 625 mg | 17Mfg 2019-11 · Exp 2021-04 | Dissolution & Assay of Potassium ClavulanateAssay | CDL KolkataCDSCO lab | Feb 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.